We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Certara Inc
4 own
4 watching
Current Price
$19.13
$0.04
(0.21%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
3,056.62M
52-Week High
28.62
52-Week Low
10.6
Average Volume
0.44M
Dividend Yield
--
P/E Ratio
--
Market Capitalization3,056.62M52-Week High28.6252-Week Low10.6Average Volume0.44MDividend Yield--P/E Ratio--What does the Certara Inc do?
We accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. Biosimulation is a powerful technology used to conduct virtual trials using virtual patients to predict how drugs behave in different individuals. Biopharmaceutical companies use our proprietary biosimulation software throughout drug discovery and development to inform critical decisions that not only save significant time and money but also advance drug safety and efficacy, improving millions of lives each year. --- Certara, Inc. was incorporated in Delaware on June 27, 2017. Our principal executive offices are located at 100 Overlook Center, Suite 101, Princeton, New Jersey 08540. Our telephone number is (609) 716-7900. Our website address is www.certara.com.
Read More
How much money does Certara Inc make?
News & Events about Certara Inc.
Zolmax
18days ago
Shares of Certara, Inc. (NASDAQ:CERT Get Rating) have received an average recommendation of Moderate Buy from the eight analysts that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the ...
Globe Newswire
25days ago
Certara improves software capabilities by expanding into deep learning and data fabricPRINCETON, N.J., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT),today announced it hasacquiredVyasaAnalytics, LLC. Vyasaprovides scalable deep-learning software whichallowslife sciences ...
Zolmax
1month ago
Certara, Inc. (NASDAQ:CERT Get Rating) major shareholder Avatar Parent L.P. Eqt sold 29,954,521 shares of Certara stock in a transaction dated Thursday, December 8th. The shares were sold at an average price of $15.00, for a total value of $449,317,815.00. The sale was disclosed in a legal filing ...
Ticker Report
1month ago
Certara, Inc. (NASDAQ:CERT Get Rating) major shareholder Avatar Parent L.P. Eqt sold 29,954,521 shares of the firms stock in a transaction on Thursday, December 8th. The stock was sold at an average price of $15.00, for a total value of $449,317,815.00. The sale was disclosed in a ...
Globe Newswire
5 months ago
PRINCETON, N.J., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor conferences: Morgan Stanley 20th Annual Global Healthcare ConferenceDate and Time: Tuesday, September ...
Frequently Asked Questions
Frequently Asked Questions
What is Certara Inc share price today?
Can Indians buy Certara Inc shares?
How can I buy Certara Inc shares from India?
Can Fractional shares of Certara Inc be purchased?
What are the documents required to start investing in Certara Inc stocks?
What is today’s traded volume of Certara Inc?
What is today’s market capitalisation of Certara Inc?
What is the 52-Week High and Low Range of Certara Inc?
What percentage is Certara Inc down from its 52-Week High?
What percentage is Certara Inc up from its 52-Week Low?
Current Price
$19.13
$0.04
(0.21%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.